Tsn.org.tw

(myeloma kidney with crystal nephropathy) [1] acyclovir sulfonamide methotrexate triamterene indinavir [2] felbamate [3] piridoxylate primidone Acyclovir
Acyclovir
Sulfonamide
Methotrexate
Triamterene (pH
Sulfonamides
Methotrexate
Triamterene
8. Poisindex(R) managements: Acyclovir and related agents (internet version), MICROMEDEX, Greenwood Village, CO,2003.
9. Rauber-Lutty CH, Lanzicher L, Guirguis M: Acyclovir over- dose in a newborn with consecutive renal impairment
(abstract). J Toxicol-Clin Toxicol 2001; 39: 506-7.
10. Boulieu R, Bastien O, Gaillard S: Pharmacokinetics of acyclo- vir in patients underlying continuous venous dialysis. Ther
Drug Monit 1997; 19: 701-4.
11. Poisindex(R) managements: Sulfonamides (internet version), MICROMEDEX, Greenwood Village, CO, 2003.
12. Lisa Malinarne et al: Primary brain abscess with Norcardia farcinica in an immunocompetent patient. Clin Neurol Neuro-
surgey 2002; 104: 132-5.
13. Sasson JP, Dratch PC, Shortsleave MJ: Renal ultrasound findings in sulfadiazine-induced crystalluria. Radiology 1992; 14. Poisindex(R) managements: Methotrexate and related agents (internet version), MICROMEDEX, Greenwood Village, CO,2003.
15. Product information:Methotrexate, methotrexate. ESI Lederle, 16. Chetham WW, Morgan SL & Alarcon GS: Renal failure: A risk factor for methotrexate toxicity. Arthritis & Rheumatism 2000;
43: 1185-6.
17. Sasaki K, Tanaka J & Fujimoto T: Theoretically required urinary flow during high-dose methotrexate infusion. Cancer
Chemother Pharmacol 1984; 13: 9-13.
18. Wall SM, Johansen MJ, Molony DA, Dubose TD, Jaffe N, 1. Kanno Y, Okada H, Nemoto H, Sugahara S, Nakamoto H, Madden T: Effective clearance of methotrexate using high- Suzuki H: Crystal nephropathy: a variant form of myeloma flux hemodialysis membranes. Am J Kidney Dis 1996; 28:
kidney-case report and review of the literature. Clin Nephrol 2001; 56: 398-401.
19. Poisindex(R) managements: Potassium sparing diuretics 2. Reilly RF, Tray K, Perazella MA: Indinavir nephropathy (internet version), MICROMEDEX, Greenwood Village, CO, revisited: a pattern of insidious renal failure with identifiable risk factors. Am J Kidney Dis 38(4): E23 [online].
20. Sica DA, Gehr TW: Triamterene and the kidney. Nephron 3. Rengstoff DS, Milstone AP, Seger DL, Meredith TJ. Clin 1989; 51: 454-61.
Toxicol: Felbamate overdose complicated by massive crys- 21. Weinberg MS, Quigg RJ, Salant DJ, Bernard DB: Anuric renal talluria and acute renal failwe. Clin Toxicol 2000; 38: 667-9.
failure precipitated by indomethacin and triamterene. Neph- 4. Fogazzi GB: Crystalluria: a neglected aspect of urinary sed- ron 1985; 40: 216-8.
iment analysis. Nephrol Dial Transplant 1996; 11: 379-87.
22. Farge D, Turner MW, Roy DR, Jothy S.: Dyazide-induced 5. Perazella MA: Crystal-induced Acute renal failure. Am J Med reversible acute renal failure associated with intracellular 1999; 106: 459-65.
crystal deposition. Am J Kidney Dis. 1986; 8: 445-9.
6. Product information: Zovirax(R), acyclovir. Glaxo Wellcome 23. Roy LF, Villeneuve JP, Dumont A, et al.: Irreversible renal Inc, Research Triangle Park, NC, 2001.
failure associated with triamterene. Am J Nephrol 1991; 11:
7. RTECS: Registry of toxic effects of chemical substances.
National institute for occupational safty & health, Cincinnati, 24. Product information: Dyrenium(R) capsules, triamterene.
OH (internet version), MICROMEDEX, Greenwood Village, Wellspring Pharmaceutical Corporation, Neptune, NJ,

Source: http://www.tsn.org.tw/tsnFile/journal/catalog/399/025-033.pdf